Chemotherapy induced neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: a cohort study

Pashtoon Murtaza Kasi, Takayuki Yoshino, Atsushi Ohtsu et al.|BMC Cancer|2016

Cited by 75